Nobilis Health Corp. (NRTSF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Nobilis Health Corp. (NRTSF) trades at $0.000001 with AI Score 49/100 (Grade C). Nobilis Health Corp. operates and develops outpatient surgery centers, focusing on delivering innovative surgical services through its medical and marketing services segments. Sector: Healthcare.
Price as of Aug 20, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for NRTSF: NRTSF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NRTSF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
NRTSF: 2/3 scored disciplines lean bullish. Dominant signal: Seth Klarman bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Nobilis Health Corp. (NRTSF) Healthcare & Pipeline Overview
Nobilis Health Corp., founded in 2007, operates outpatient surgery centers, providing medical and marketing services. With a focus on ambulatory and acute care facilities, the company delivers surgical services, patient education, and care coordination. Trading on the OTC market, Nobilis faces liquidity and disclosure challenges typical of this tier.
What Is the Investment Thesis for NRTSF?
Nobilis Health Corp. presents a speculative investment opportunity due to its presence in the growing outpatient surgery center market. The company's gross margin of 62.4% indicates potential profitability if operational efficiencies are improved. However, the company's OTC listing and lack of dividend payment introduce significant risk. Key value drivers include expanding the network of outpatient facilities and increasing patient volume through effective marketing strategies. Growth catalysts involve capitalizing on the increasing demand for outpatient surgical procedures and forming strategic partnerships with healthcare providers. Potential risks include regulatory changes, competition from larger healthcare providers, and the challenges associated with operating in the OTC market, including limited liquidity and disclosure requirements. Investors should carefully consider these factors before investing in NRTSF.
Based on FMP financials and quantitative analysis
NRTSF Key Highlights
Gross margin of 62.4% indicates potential for profitability if operational efficiencies are improved.
- Operates in the outpatient surgery center market, which is experiencing growth due to cost-effectiveness and patient convenience.
- Employs 700 individuals, suggesting a significant operational scale.
- Headquartered in Houston, TX, indicating a regional focus with potential for expansion.
- Profit margin of 1.3% suggests challenges in converting revenue to profit.
Who Are NRTSF's Competitors?
NRTSF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BICX BioCorRx Inc. | $0.24 | +0.00% | $6.34M | 52 |
| FTRP Field Trip Health Ltd. | $0.84 | +1.07% | $9.81M | 62 |
| CANO Cano Health, Inc. | $2.30 | -2.13% | $12.4M | 52 |
| NVLPF Nova Leap Health Corp. | $0.36 | +5.30% | $31.4M | 55 |
| ASSF Assisted 4 Living, Inc. | $1.00 | +0.00% | $45.4M | 63 |
| BTMD biote Corp. | $1.44 | +5.88% | $63.5M | 66 |
| JYNT The Joint Corp. | $8.23 | -3.63% | $117M | 75 |
| HWAIF Healwell AI Inc. | $0.57 | +3.64% | $172M | 65 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NRTSF's Key Strengths?
Established network of outpatient surgery centers.
- Integrated medical and marketing services.
- Focus on patient care coordination.
- Expertise in managing ambulatory and acute care facilities.
What Are NRTSF's Weaknesses?
OTC market listing limits access to capital and investor base.
- Low profit margin of 1.3% indicates operational inefficiencies.
- High beta of -328.99 suggests extreme volatility.
- Dependence on outpatient surgical procedures, making it vulnerable to changes in healthcare regulations.
What Could Drive NRTSF Stock Higher?
Expansion of outpatient surgery center network to new geographic markets.
- Implementation of advanced surgical technologies to improve patient outcomes.
- Strategic partnerships with healthcare providers to expand referral network.
- Potential for increased patient volume through targeted marketing campaigns.
- Possible improvements in operational efficiency leading to higher profit margins.
What Are the Key Risks for NRTSF?
Financial-distress signal — its Altman Z-Score of 0.87 sits in the distress zone (elevated bankruptcy risk).
- Inconsistent delivery — missed Wall Street EPS estimates in 5 of the last 8 reported quarters.
- Regulatory changes impacting reimbursement rates for outpatient surgical procedures.
- Increased competition from larger healthcare providers with greater resources.
- Economic downturn affecting patient demand for elective procedures.
- Limited liquidity and transparency due to OTC market listing.
- Potential for medical malpractice claims and litigation.
What Are the Growth Opportunities for NRTSF?
- Expanding the network of outpatient surgery centers: Nobilis has the opportunity to grow by establishing new facilities in underserved markets or acquiring existing centers. The outpatient surgery center market is projected to reach $45 billion by 2028, offering significant growth potential. This expansion would increase patient access and revenue streams, enhancing the company's market position. Timeline: Ongoing.
- Increasing patient volume through targeted marketing: Nobilis can enhance its marketing efforts to attract more patients to its facilities. This includes digital marketing, partnerships with physicians, and community outreach programs. Effective marketing can drive patient referrals and increase the utilization of the company's services. The market for medical marketing is expected to grow to $40 billion by 2027. Timeline: Ongoing.
- Adopting advanced surgical technologies: Investing in advanced surgical technologies can improve patient outcomes, reduce recovery times, and attract more patients. This includes robotic surgery, minimally invasive techniques, and advanced imaging systems. Timeline: Ongoing.
- Forming strategic partnerships with healthcare providers: Collaborating with hospitals, physician groups, and insurance companies can expand Nobilis's reach and referral network. These partnerships can provide access to a broader patient base and enhance the company's reputation. Strategic alliances can also lead to shared resources and cost savings. Timeline: Ongoing.
- Enhancing patient care coordination services: Improving patient care coordination can lead to better patient outcomes, increased patient satisfaction, and reduced readmission rates. This includes providing personalized care plans, coordinating appointments, and offering post-operative support. Enhanced care coordination can differentiate Nobilis from its competitors and attract more patients. Timeline: Ongoing.
What Are NRTSF's Competitive Advantages?
- Established network of outpatient surgery centers.
- Integrated medical and marketing services.
- Focus on patient care coordination.
- Expertise in managing ambulatory and acute care facilities.
What Does NRTSF Do?
Founded on March 16, 2007, and headquartered in Houston, TX, Nobilis Health Corp. is dedicated to the operation and development of outpatient surgery centers. The company owns and manages both ambulatory and acute care facilities, aiming to provide innovative surgical services. Nobilis operates through two primary segments: Medical Services and Marketing Services. The Medical Services segment encompasses the operation of hospitals, outpatient facilities, and a range of related healthcare services. This includes surgical procedures, post-operative care, and other medical treatments. The Marketing Services segment focuses on marketing initiatives, patient education programs, and patient care coordination management. This involves attracting patients to the facilities, educating them about available treatments, and ensuring seamless care transitions. Nobilis aims to differentiate itself through its integrated approach, combining medical expertise with patient-centric marketing and care coordination. The company's business model focuses on providing high-quality surgical services in a cost-effective outpatient setting. As of 2026, Nobilis continues to navigate the competitive healthcare landscape, focusing on operational efficiency and strategic growth initiatives.
What Products and Services Does NRTSF Offer?
- Operate outpatient surgery centers.
- Develop new outpatient surgery centers.
- Manage ambulatory care facilities.
- Manage acute care facilities.
- Provide medical services, including surgical procedures.
- Offer marketing services to attract patients.
- Provide patient education services.
- Coordinate patient care management.
How Does NRTSF Make Money?
- Generate revenue through medical services provided at outpatient surgery centers.
- Earn revenue from marketing services offered to patients.
- Focus on ambulatory and acute care facilities to deliver surgical services.
- Coordinate patient care to ensure seamless transitions and improve outcomes.
What Industry Does NRTSF Operate In?
Nobilis Health Corp. operates within the medical care facilities industry, which is part of the broader healthcare sector. The industry is characterized by increasing demand for outpatient services due to their cost-effectiveness and convenience compared to traditional hospital settings. The market is competitive, with players ranging from large hospital systems to smaller independent surgery centers. Nobilis competes with companies like ACUS, AOBI, APYI, CDXI, and ENCW. The industry is subject to regulatory oversight and reimbursement pressures, impacting profitability and growth. Market trends include the adoption of advanced surgical technologies and the shift towards value-based care models.
Who Are NRTSF's Key Customers?
- Patients seeking outpatient surgical procedures.
- Individuals requiring ambulatory care services.
- Patients needing acute care services.
- Healthcare providers seeking partnerships for patient care coordination.
Key Financial Metrics
Return on equity for Nobilis Health Corp. stands at 2.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.9%, showing how much profit it generates from its asset base. NRTSF trades at a trailing price-to-earnings ratio of 0.00, below the Healthcare sector average of ~23x. A current ratio of 2.12 indicates the company holds enough short-term assets to cover its near-term obligations.
Nobilis Health Corp. (NRTSF) Valuation Context
Relative to its peer group, NRTSF's quantitative score of 49/100 is roughly in line with the peer average of 57/100.
Company Profile
Nobilis Health Corp. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Houston, CA. The company is led by CEO Patrick Yoder. NRTSF has traded publicly since 2011.
Financial Health
Nobilis Health Corp.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.87 places it in the distress zone, a signal of elevated financial risk.
Earnings Track Record
Nobilis Health Corp. has missed Wall Street's EPS estimate in 5 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 68.9% below estimates on average.
NRTSF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests those with the deepest knowledge of Nobilis Health Corp. see value at current levels, potentially signaling future growth.
- Positive community sentiment indicates growing investor confidence in the company's strategic direction and market positioning.
- Bullish community views highlight the potential for Nobilis Health Corp. to capitalize on emerging healthcare trends and expand its service offerings.
- Market perception suggests Nobilis Health Corp. is gaining traction in the competitive healthcare landscape, attracting attention from institutional investors and strategic partners.
Bear Case
- Recent lack of significant news may be causing investor apathy, leading to stagnant stock performance and reduced trading volume.
- Bearish community views express concern about the company's ability to navigate regulatory challenges and maintain profitability.
- Market perception indicates Nobilis Health Corp. faces increasing competition from larger healthcare providers with greater resources and brand recognition.
- Community sentiment reveals worries about the company's debt levels and its ability to generate sufficient cash flow to meet its financial obligations.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
NRTSF Latest News
No recent news available for NRTSF.
NRTSF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NRTSF.
Price Targets
Wall Street price target analysis for NRTSF.
NRTSF MoonshotScore
What does this score mean?
The MoonshotScore rates NRTSF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Patrick Yoder
CEO
Patrick Yoder is the CEO of Nobilis Health Corp. He is responsible for managing the company's operations and strategic direction. His background includes experience in healthcare management and business development. He oversees a workforce of 700 employees and is focused on expanding the company's network of outpatient surgery centers. Prior to Nobilis, Yoder held leadership positions in various healthcare organizations, focusing on improving patient care and operational efficiency.
Track Record: Under Patrick Yoder's leadership, Nobilis Health Corp. has focused on expanding its network of outpatient surgery centers and enhancing its marketing efforts to attract more patients. Key milestones include implementing advanced surgical technologies and forming strategic partnerships with healthcare providers. Yoder has also focused on improving patient care coordination and reducing readmission rates. However, the company's financial performance has been inconsistent, with challenges in achieving sustained profitability.
NRTSF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Nobilis Health Corp. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be required to provide regular financial disclosures. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight compared to exchanges like the NYSE or NASDAQ. This tier is often populated by shell companies, bankrupt entities, or companies with questionable business practices.
- OTC Tier: OTC Other
- Limited liquidity due to low trading volume.
- Lack of transparency due to limited financial disclosures.
- Potential for price manipulation and fraud.
- Higher risk of delisting or going out of business.
- Limited regulatory oversight compared to listed exchanges.
- Verify the company's legal standing and business operations.
- Obtain and review audited financial statements.
- Assess the company's management team and their track record.
- Evaluate the company's competitive position and market outlook.
- Understand the company's capital structure and debt obligations.
- Determine the reasons for the OTC listing and any past regulatory issues.
- Consult with a financial advisor and conduct thorough research before investing.
- Operation of outpatient surgery centers indicates real business activity.
- Employee count of 700 suggests a substantial operational scale.
- Gross margin of 62.4% suggests potential for profitability.
- Existence of a CEO (Patrick Yoder) and management team.
- Company founded in 2007 indicates a history of operations.
Nobilis Health Corp. Healthcare Stock: Key Questions Answered
What does the AI Score mean for NRTSF?
NRTSF holds an AI Score of 49/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Nobilis Health Corp. operates and develops outpatient surgery centers, focusing on delivering innovative surgical services through its medical and marketing services segments. The company manages …
What does Nobilis Health Corp. do?
Nobilis Health Corp. operates and develops outpatient surgery centers, focusing on providing innovative surgical services. The company owns and manages ambulatory and acute care facilities, offering a range of medical services, including surgical procedures, post-operative care, and patient care coordination. Nobilis also provides marketing services to attract patients and educate them about available treatments.
What are the main risks for NRTSF?
The main risks for Nobilis Health Corp. include regulatory changes impacting reimbursement rates, increased competition from larger healthcare providers, and economic downturns affecting patient demand for elective procedures. Additionally, the company faces risks associated with its OTC market listing, including limited liquidity, lack of transparency, and potential for price manipulation.
What are the key factors to evaluate for NRTSF?
Nobilis Health Corp. (NRTSF) holds an AI score of 49/100 (low). presents a speculative investment opportunity due to its presence in the growing outpatient surgery center market. Not financial advice.
How frequently does NRTSF data refresh on this page?
NRTSF's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven NRTSF's recent stock price performance?
Nobilis Health Corp. (NRTSF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established network of outpatient surgery centers. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NRTSF overvalued or undervalued right now?
Nobilis Health Corp. (NRTSF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research NRTSF before investing?
Before investing in Nobilis Health Corp. (NRTSF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding NRTSF to a portfolio?
Key strength of Nobilis Health Corp. (NRTSF): Established network of outpatient surgery centers. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available due to OTC market listing.
- AI analysis pending, so some sections are based on limited data.
- Financial data may not be current or reliable.